Filing Details
COLLEGIUM PHARMACEUTICAL, INC (NASDAQ:COLL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:COLL
COLLEGIUM PHARMACEUTICAL, INC (COLL) Files Quarterly Report for Q0
COLLEGIUM PHARMACEUTICAL, INC (NASDAQ:COLL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
At publication ·
What changed
COLLEGIUM PHARMACEUTICAL, INC (NASDAQ:COLL) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Collegium Pharmaceutical filed its Q0 2026 quarterly report (10-Q) on November 5, 2026 with the SEC.
- The company's stock trades at $23.67 per share with a market capitalization of $1.5 billion.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance and emerging risks.
Market Context
COLLEGIUM PHARMACEUTICAL, INC's stock currently trades at $23.67 with a market capitalization of $1.5B.
The 10-Q provides COLLEGIUM PHARMACEUTICAL, INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for COLLEGIUM PHARMACEUTICAL, INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View COLL Stock Page
Frequently Asked Questions
Where can I read COLL's SEC filings?
Browse all filings on our COLL SEC filings page.
What types of SEC filings does COLLEGIUM PHARMACEUTICAL, INC file?
Public companies like COLLEGIUM PHARMACEUTICAL, INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.